Hair Disorders A Case Based Approach

Similar documents
Disclosure Statement: Life Cycle of a Hair. Objectives. Life Cycle of a Hair. Hair Classification. Hair Disorders A Case Based Approach

Disclosure Statement:

Hair and Nail Disorders

Diagnosis and Management of the Hair Loss Patient: Pearls and Pitfalls

GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM

FAST FACTS FOR BOARD REVIEW

HOW TO BEST MANAGE ALOPECIA IN Kristen Fernandez, MD Department of Dermatology University of Missouri Harry S Truman VA

Staying A- Head in Pediatric Dermatology:

Tips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic

Dutasteride female pattern hair loss management 49, 50 male baldness management 41, 42 Dyeing, see Hair care

Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery

New Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology

Poonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital

Snapshot Dx Quiz: September 2018 Detailed Answers

What Are the Different Forms?

Tips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter

Dermatopathology Workshop Summary, Berlin 2004

How to decipher a pathology report for alopecia

What s New in Alopecia Areata

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Daniel Asz Sigall, MD MEXICO

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Index. B Bcl-2 expression, 111 Behavioral therapy, 65 Beta blockers, 20, 76 Biopsy, 10, 25, 57, 72

CLASSIFICATION OF AGA IN MALES: THE HAMILTON-NORWOOD SYSTEM DISCLOSURE OF CONFLICTS OF INTEREST

Hair loss is stressful and cosmetically concerning

Lichen planopilaris and its variants. Antonella Tosti. Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery

Diphencyprone (DCP) treatment

Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience

Dermoscopic Approach to a Small Round to Oval Hairless Patch on the Scalp

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

CHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia

RESENT TREATMENT OF ALOPECIA AREATA

Common causes of paediatric alopecia

The value of dermoscopy in diagnosing eyebrow loss in patients with alopecia areata and frontal fibrosing alopecia

Outline. Chronic Urticaria. Dermatology Pearls for the Primary Care Practitioner

Update on African American Hair and Scalp Disorders

Is Platelet Rich Plasma Injection an Effective Treatment for Hair Loss in Androgenic Alopecia and Alopecia Areata?

TINEA (FUNGAL) INFECTION

Nkanyezi Ferguson, MD, FAAD University of Iowa Hospital and Clinics Iowa City, IA

FIBROSING ALOPECIA IN A PATTERN DISTRIBUTION IN TWO BROTHERS WITH PILI MULTIGEMINI

STUDY. Histopathologic Features of Alopecia Areata

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page

Tinea: Head to Toe A dermatophyte tour of human skin. Tour de Tinea Head to Toe. Tips for Tinea Head to Toe. Psoriasis. Non-inflammatory Tinea Capitis

Authors: Raja ni N a lluri A a nd M at t hew H a r rie s B. Hair follicles, the hair cycle and hair loss ABSTRACT. Introduction

Clinicopathologic Self-Assessment

CLINICAL REVIEW. Management of alopecia areata. M J Harries, 1 J Sun, 2 3 R Paus, 1 4 L E King 5. For the full versions of these articles see bmj.

Shedding: How to manage a common cause of hair loss

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada

Questions 1. What is the diagnosis? 2. What is the significance? 3. What is the treatment? Provided by: Dr. Alexander K.C. Leung

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Seborrheic dermatitis. What is SEBORRHEIC DERMATITIS? This is a common condition which affects 1-3 % of individuals.

Hair Research in 2017: A Look Back at 20 Research Papers that Influenced My Practice. Jeff Donovan MD PhD, Dermatologist Vancouver, Canada

Female pattern hair loss

Clinical Policy Title: Alopecia areata

Male pattern hair loss: current understanding

NOW. ce lesson. At a loss: Alopecia By Karen Jensen, MSc, BSP and Dorothy Sanderson, BSP FREE!

X-Plain Acne Reference Summary

Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia

2-Hypertrichosis:- Hypertrichosis is the

FACULTY DISCLOSURE PRACTICE CHANGE

CORE CURRICULUM IN HAIR RESTORATION SURGERY Revised July 22, 2009

Tufted folliculitis of the scalp: a distinctive clinicohistological variant of folliculitis decalvans

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Alopecia. Antonella Tosti. Fredric Brandt Endowed Professor of Dermatology&Cutaneous Surgery Miller School of Medicine, University of Miami

Clinical Policy Title: Alopecia areata

Prevalence of Hair loss and stress as the cause; a cross-sectional study.

Hair disorders Antonella Tosti

6/30/2015. Many patients with more than one form of alopecia, but they think of it as one entity. and Gamble, Galderma, Sanumed

Endocrine Therapy-Induced Alopecia (EIA) Mario E Lacouture MD Member, Memorial Hospital Director, Oncodermatology Program New York, NY

HIDRADENITIS SUPPURATIVA

Central centrifugal cicatricial alopecia an approach to diagnosis and management

DERMCASE. Swelling of the Face. Case White Toenails p Skin Papules p Patches of Hair p.34

Impact of Cancer Therapies on Hair and Management Strategies

Clinical Policy Title: Alopecia areata

Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and posttreatment

This section covers the basic knowledge of normal skin structure and function required to help understand how skin diseases occur.

Three clinical cases. fungal infections

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

PROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP

Efficacy of Topical Diphencyprone in the Treatment of Alopecia Areata

Conflicts of interest

SHORT REPORT FRONTAL FIBROSING ALOPECIA IN A PREMENOPAUSAL WOMAN: IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENCE ANALYSIS

Hair and nails. Dermatology. Hair. Structure and function. Hypertrichosis too much hair. Hirsutism hair in the wrong spot. Background.

TUFTED FOLLICULITIS: AN EASILY MISSED ENTITY Sowmya Naga Dogiparthi 1, M. Krishnakanth 2, S. Adikrishnan 3, Adithya B 4, Sudha R 5

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Psoriatic Scarring Alopecia

Outline Dermatomycoses Definition: diseases or fungal infections of the skin Transmission of Dermatomycoses Case Report 1 Presentation of Disease

JERRY SHAPIRO, MD, FAAD PROFESSOR

INTRALESIONAL PLATELET RICH PLASMA vs INTRALESIONAL TRIAMCINOLONE IN THE TREATMENT OF ALOPECIA AREATA: A COMPARATIVE STUDY

Emergent and Urgent Dermatology, Eruptions, and Wound Care

Severe kerion celsi effectively treated with skin debridement and antifungals

Note for John Doe on 02/08/ Chart 17492

Diphencyprone (DPC) treatment for Alopecia Areata

Scabies. Scabies 10/22/2012. What s Bugging You? Common Cutaneous Infections and Infestations in Kids

Psoriasis. Jessica Kaffenberger, M.D. Assistant Professor of Dermatology Division of Dermatology The Ohio State University Wexner Medical Center

Classification. Distal & Lateral Subungual OM. White Superficial OM. Proximal Subungual OM. Candidal OM. Total dystrophic OM

CERTIFICATION COURSES Information and Application

Transcription:

Hair Disorders A Case Based Approach Daniel Stulberg, MD Professor of Family and Community Medicine University of New Mexico Some slides courtesy E.J. Mayeaux, Jr., MD 1

Disclosure Statement: Co-Author, Dermatologic and Cosmetic Procedures in Office Practice. Elsevier, Inc., Philadelphia. 2012. Cutaneous Cryosurgery. Fourth Edition. CRC press 2014. 2

Objectives Recognize normal hair anatomy and physiologic changes in hair Evaluate the chief complaint of hair loss Utilize effective medical interventions for hair disorders, when appropriate 3

Life Cycle of a Hair Anagen phase (active growth) - 2-7 years Catagen (transitional/follicular regression) - 2-3 weeks Telogen (preshedding or rest) about 3 Months Hair released and shed at end of telogen > 85% of hairs of the scalp are in anagen Longer anagen phase = Longer hair 4

Life Cycle of a Hair We have all terminal hair follicles at birth Hair grows at 0.35 mm/day = 1 cm /month Each hair follicle s cycle is usually asynchronous with others around it We lose ~75-100 hairs a day Same number of hairs enter anagen phase Telogen hairs are characterized by a mature root sheath, or "club," at the proximal end Price VH. Treatment of hair loss. N Engl J Med 1999; 341:964. 5

Hair Classification Terminal (large) hairs Found on the head and beard Larger diameters and roots that extend into sub q fat Daniel Stulberg, MD 6

Hair Classification Vellus hairs are smaller in length and diameter and have less pigment Intermediate hairs have mixed characteristics Daniel Stulberg, MD 7

Alopecia Definition Partial or complete loss of hair from where it would normally grow Celestino FS, Alopecia. In: Mengel MB, Schwiebert LP, eds Ambulatory Medicine. Stamford, Conn: Appleton & Lange; 1996: Can be total, diffuse, patchy, or localized Daniel Stulberg, MD Daniel Stulberg, MD 8

Classification of Alopecia Neoplastic Nevoid Scarring Injury such as burns Cicatricial Inflammatory Systemic illnesses (LE) Nonscarring Medications Congenital Infectious Genetic (male pattern) Toxic (arsenic) Nutritional Traumatic Endocrine Immunologic Physiologic 9

General Evaluation of Hair Loss History Shedding vs. thinning Duration of problem Pertinent family hx Grooming practices Medications Serious past or current illnesses 10

Physical Pattern of hair loss Patchy or localized = confined to several areas of the scalp leaving some areas unaffected Diffuse implies uniform density decrease Examine the scalp for erythema, scale, pustules, bogginess, edema, loss of follicle openings, scarring or sinus tracts Check for follicular ostia and broken hairs Hair fragility Squeeze and roll hair within a gauze pad If fragile, short fragments remain on the pad 11

Evaluation Hair pull test 50-60 hairs are grasped firmly in thumb & forefinger and steady traction applied as fingers dragged along the lengths of hairs >6 hairs = loss Examine microscopically May consider scalp punch biopsy Trim hair, inject 1-3 cc of lido with epi, use a 4mm punch, place single suture Attempt to get both affected and normal 12

Laboratory Studies TPab or RPR/VDRL KOH prep or PAS for fungal elements Use in patchy hair loss Hair shaft stubs from periphery of lesion Can obtain culture for fungi 13

Male pattern baldness Complain of thinning vs. shedding Affects 70-80% of men 30-50% of women Higher local levels Dihydrotestosterone Miniaturization of hair follicles Androgenic/Androgenetic Alopecia Daniel Stulberg, MD 14

Androgenic Alopecia Crown Frontal Temples Sparing of occipital and lower parietal fringe of hair Daniel Stulberg, MD 15

Androgenic Alopecia Multiallelic trait Obtain history of baldness in grandparents and 1 st - degree relatives on both maternal and paternal sides of family Daniel Stulberg, MD 16

Hair Case 45 year old woman Progressive hair loss No PMH No virilization/acne/voice changes/clitoromegaly 17

Daniel Stulberg, MD 18

Female Pattern Hair Loss Strong family history common Just like Male pattern baldness Follicular miniaturization No endocrine work up needed Minoxidil for women 2% (Rogaine) 1ml BID Minoxidil for men 5% Prolongs anagen phase 19

Cochrane 10/16 Minoxidil 2% = Minoxidil 5% Increased 13.8 hairs/cm Moderate to greatly increased hair growth 40-45% pts Finasteride No help 20

Female Virilization Anabolic steroid use Ovarian Adrenal Hormone eval Consider imaging ovaries & adrenal glands 21

Androgenic Alopecia Treatment Topical minoxidil or oral finasteride Finasteride (Propecia)1mg PO (5mg on $4 plans can use ¼ tab) Minoxidil 5% 1ml BID Minoxidil 2% 1ml BID (Rogaine) No head to head comparisons Both beneficial compared to placebo Finasteride 66%, 39% age 18-40, 41-60 Inc hair growth JAAD 2012 22

Androgenic Alopecia Treatment 5 alpha reductase inhibitors Dec testosterone Dec libido ED Off label dutasteride 5 alpha reductase inhibitor 0.5mg QD 6 mos males 18-49 12.2 vs 4.7 hairs/cm increase 23

Androgenic Alopecia Treatment Surgical treatment Micrografting Platelet rich protein injections 36 hairs/cm inc at 3 months Int J Mol Sci 2/17 Plugs Scalp reduction 24

Hair loss Case 25 YO man no PMH Hair cut 1 week ago Noted patch of hair loss 3 days later No other sx 25

Daniel Stulberg, MD 26

Daniel Stulberg, MD 27

Different patient Daniel Stulberg, MD 28

Pull Test Exclamation point hairs Normal Anagen phase 29

Another Example - Eyebrows Daniel Stulberg, MD 30

Another Example - Eyelashes Daniel Stulberg, MD 31

Alopecia Areata Focal patches Smooth base Easily pulled hairs at margin Non scarring Poss auto-immune Poss correlation with Vitiligo, thyroid dz,?dm Often + Family HX Commonly starts in childhood Daniel Stulberg, 32MD

4 yr old - hair loss at age 2 regrew now losing again Daniel Stulberg, MD 33

Daniel Stulberg, MD 34

Alopecia Areata Usually circumscribed patches Total scalp (Totalis) Entire body (Universalis) Daniel Stulberg, MD Dr Richard Usatine, courtesy of The Color Atlas of Family Medicine 35

Alopecia Areata Poorer prognosis with Severe disease (esp. Totalis/Universalis) Nail pitting, splitting Peripheral scalp disease Onset before puberty Duration >1 yr. 36

Alopecia Areata Treatment - EBM Few treatments for alopecia areata have been well evaluated in RTCs. We found no RCTs on the use of diphencyprone, DNCB, intralesional steroids or dithranol, although they are commonly used. Although topical steroids and minoxidil are widely prescribed and appear to be safe, there is no convincing evidence that they are beneficial in the long term. Considering the possibility of spontaneous remission especially in the early stages, the option of not being treated may be an alternative way of dealing with this condition Cochrane Database of Systematic Reviews 4/2016 37

Alopecia Areata Treatment Reassurance - 50-80% limited cases regrow May ask for tx even for a small patch Minoxidil 5% Topical steroids Clobetasol propionate 0.05% vs. hydrocortisone 1% Age 2-16 >10% hair loss 17/20 vs. 7/21 with 50% reduction in SA at 24wks JAMA Dermatology 1/2014 38

Alopecia Areata Treatment Potent topical steroids Fluocinolone acetonide cream 0.2% (Synalar) Betamethasone dipropionate 0.05% (Diprosone) Less effective than injection* Mild cases (<10% scalp) - intralesional steroids to decrease inflammation around the follicle May pretreat with topical anesthetic cream Severe forms hard to treat - refer *Devi M, Rashid A, Ghafoor R. Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata. J Coll Physicians Surg Pak. 2015 Dec. 25 (12):860-2 39

Alopecia Areata Treatment Intralesional steroids - triamcinolone acetonide (Kenalog) 2.5-10mg/ml Up to 4ml Inject while advancing needle using only enough to blanch the skin momentarily or 0.1 ml every 1cm Can repeat q 4-6 weeks Major side effect is skin atrophy Dr Richard Usatine, courtesy of The Color Atlas of Family Medicine 40

Alopecia Areata Treatment Systemic steroids for larger areas May lose hair when tapered or D/C Minoxidil 5% topically BID w/without steroids but success is varied and is slow 8-45% success rates* 5% distant hypertrichosis Topical immunotherapy with diphenylcyclopropenone (DPCP), squaric acid dibutylester (SADBE), or dinitrochlorobenzene (DNCB) is probably the most effective treatment *Bolduc, C E-Medicine 2016 41

Alopecia Areata Treatment Off label Cyclosprine Methotrexate TNF alpha inhibitors adalimumab, etanercept Janus kinase inhibitors case reports ruxolitinab, tofacitinib Int J of Derm 3/2017 42

Hair Loss Case 25 YO G1P1 5.5 months s/p NSVD uncomplicated Losing hair diffusely following preg Clumps of hair in shower 43

Daniel Stulberg, MD 44

Anagen hair bulb Bulb in telogen phase Daniel Stulberg, MD 45

Telogen Effluvium Acute hair loss (up to 20% at peak) Most common cause of diffuse hair loss Occurs 3-4 months after a trigger Pregnancy, severe wt. loss, major illness, traumatic, psych events Women > men Non focal Mild or no visible thinning Anagen hairs precipitated into catagen At telogen hairs abruptly fall out 46

Telogen Effluvium Patients often do not associate with precipitating illness due to time interval Drugs can cause telogen effluvium PTU, Tapazole, heparin, and warfarin Hypervitaminosis A Pull test: > 5-6 telogen hairs Lab: TSH, iron studies, Tpab, RPR or VDRL No specific treatment 47

Hair Loss Case 15 yo many years of hair loss PMH Depression O/W denies Asymptomatic 48

Daniel Stulberg, MD 49

Daniel Stulberg, MD 50

Trichotillomania 2-3% of all people with hair loss Strange pattern No inflammation Varying length of hair HX depression, anxiety, hair twirling Frequent trichophagia, sometimes bezoars 51

Trichotillomania Mean onset age 13 Dx usually by the pattern of loss, sometimes with unusual shapes Women > men Daniel Stulberg, MD 52

Trichotillomania - Broken hairs Daniel Stulberg, MD 53

Trichotillomania Usually not scarring, but plucking over years may result in immune cell infiltrate Pluck test Wear gloves if difficult to pluck Lab consider TPab or RPR, TSH Treatment Behavior modification? SSRI antidepressants Daniel Stulberg, MD 54

EBM Recommendation No particular medication class definitively demonstrates efficacy in the treatment of trichotillomania. Preliminary evidence suggests treatment effects of clomipramine, NAC and olanzapine based on three individual trials, albeit with very small sample sizes. Cochrane review Pharmacotherapy for trichotillomania Rothbart, R et al November 2013 Deepmala et al Clinical trials of N-acetylcysteine in psychiatry and neuorology:a systematic review. Neurosci Biobehav Rev 2015 Aug;55:294-321 55

Traction Alopecia Unintentional traumatic hair loss Often seen in athletes and African-Americans when hair is placed in tight braids / styles Outermost hairs subjected to most tension Given time, a zone of alopecia results between braids and along scalp margin Mitchell Pratte, DO 56

Traction Alopecia Temporal, frontal and periauricular regions of scalp Rx = hair restoration techniques Daniel Stulberg, MD 57

Hair Loss Case 25-year-old African-American man Papular rash for 2 years following a short haircut Initially pustules, itching and inflammation Now slowly enlarging papules 58

Daniel Stulberg, MD 59

Daniel Stulberg, MD 60

Daniel Stulberg, MD 61

Polytrichia Daniel Stulberg, MD 62

Acne Keloidalis African descent Curly hair Inflammatory papules Avoid razors, short hair? Not keloid formers? Topical steroids Injected steroids Oral ABX Surgical Madu P, Kundu RV. Follicular and scarring disorders in skin of color:presentation and management. Am J Clin Dermatol. 2014 Aug;15(4):307-21. 63

Scarring Alopecias Very heterogeneous group Trend to hair destruction in early or even mild stages of the disease Hair loss permanent Erythematous papules, pustules, scarring, loss of follicle openings Polytrichia Dr Richard Usatine, courtesy of The Color Atlas of Family Medicine 64

Lupus Alopecia Most common scarring alopecia Usually affects scalp Well circumscribed, erythematous infiltrated patches w/ follicular hyperkeratosis Later atrophic smooth depressed hypopigmented patches Bx = immune deposits Tx = treat lupus 65

Lupus Alopecia Courtesy of E.J. Mayeaux, Jr., M.D. Courtesy of E.J. Mayeaux, Jr., M.D. 66

Dr Richard Usatine, courtesy of The Color Atlas of Family Medicine 67

Cicatricial Scarring Alopecias Central centrifugal cicatricial alopecia Midline and spreading Systemic ABX and topical steroids Dissecting cellulitis Isotretinoin Lichen Planopilaris Assoc w LP, inflammation at follicles Frontal fibrosing alopecia Immune suppression Steroids, cyclosporin MTX et al 68

Child with patchy hair loss, scale and tender scalp Daniel Stulberg, MD 69

Broken Hairs and Inflammation Dr Richard Usatine, courtesy of The Color Atlas of Family Medicine 70

Tinea Capitis Patchy hair loss Scalp w/ scale Broken hair shafts Invasion of follicles and hair shaft Trichophyton Tonsurans 90% in US no fluorescence Less commonly Microsporum - fluoresces green Systemic antifungals griseofulvin plus selenium or ketoconazole shampoo Kerion Scarring Steroids Fitzpatrick s General Dermatology 71

Tinea Capitis Systemic antifungals Plus selenium AVOID ketoconazole PO Kerion Scarring Steroids Adults: Griseofulvin, 20 25 mg/kg/day 6 8 weeks Terbinafine, 250 mg/day 2 8 weeks Itraconazole, 5 mg/kg/day 2 4 weeks Fluconazole, 6 mg/kg/day 3 weeks Children: Terbinafine, 3 6 mg/kg/day 2 8 weeks all others are the same Available as granules Fitzpatrick s General Dermatology 72

Best practices / Summary Reassurance or topical or injected steroids for Alopecia Areata Minoxidil for female and male pattern hair loss Systemic antifungals for tinea capitis Tretinoin or injection for acne keloidalis Isotretinoin for dissecting cellulitis Refer for scarring alopecias 73

Pattern approach Alopecia areata, totalis Adapted from Springer, Brown and Stulberg American Family Physician 7/1/2003 74